Appropriate Use Criteria for Molecular Breast Imaging
Molecular breast imaging (MBI) with 99mTc-sestamibi has evolved remarkably since its inception more than 2 decades ago. Compared with prior iterations of the technology, the high-resolution dedicated breast imaging gamma camera systems offer improved sensitivity with the use of dual-head solid-
Authors
- Sofia C. Vaz (ORCID: https://orcid.org/0000-0003-4229-9349)
- Gaiane M. Rauch (ORCID: https://orcid.org/0000-0003-2079-5202)
- Mediget K. Teshome (ORCID: https://orcid.org/0000-0001-8632-0256)
- Lioe‐Fee de Geus‐Oei (ORCID: https://orcid.org/0000-0003-1817-2743)
- Amy M. Fowler (ORCID: https://orcid.org/0000-0002-1172-1618)
- Katie N. Hunt (ORCID: https://orcid.org/0000-0003-2889-3528)
- Elizabeth H. Dibble (ORCID: https://orcid.org/0000-0002-3906-6272)
- Matthew F. Covington (ORCID: https://orcid.org/0000-0002-3613-9472)
- Ravi Jain (ORCID: https://orcid.org/0000-0003-3691-0447)
- Banu Arun
Institutions
- Champalimaud Foundation (PT)
- Mayo Clinic (US)
- The University of Texas MD Anderson Cancer Center (US)
- Brown University (US)
- UCLA Health (US)
- Leiden University Medical Center (NL)
- Rhode Island Hospital (US)
- Huntsman Cancer Institute (US)
- Connecticut Valley Hospital (US)
- University of Wisconsin Carbone Cancer Center (US)
- Systems Engineering Associates Corporation (United States) (US)
- Department of Emergency Services and Public Protection (US)
Publication Details
- Journal
- Journal of Nuclear Medicine Technology
- Published
- 2025-08-26
- DOI
- https://doi.org/10.2967/jnmt.125.270865
- Citations
- 5
- Primary Topic
- Medical Imaging Techniques and Applications
- Type
- article
- Field-Weighted Citation Impact
- 6.80